Last changed on 05 September 2019 - 08:43

Cerebral ischaemia is a pathology caused by the reduced flow of blood to the brain and it represents the third cause of death in Europe and North America. At the moment, the only possible therapeutic approach is to quickly restore the flow of blood and the only medicinal product currently used is the tissue plasminogen activator (tPA).
However, tPA can give serious side effects, it must be administered within three hours of the ischaemic episode and is not suitable for all patients.